# Can a GLP-1 Cause Thiamine Deficiency? Six Cases Say It Can | This GLP A systematic review found six published cases of Wernicke's encephalopathy after semaglutide for obesity | all six preceded by prolonged GI symptoms and rapid weight loss. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/research/can-a-glp1-cause-thiamine-deficiency Updated: 2026-09-17 Published: 2026-09-17 [← Research](https://thisglp.com/research) Safety # Can a GLP-1 Cause Thiamine Deficiency? Six Cases Say It Can Every published case began the same way. Prolonged vomiting first. Then rapid weight loss. Then neurological signs. The first two stages are the ones a reader can act on. [This GLP Editorial Team](https://thisglp.com/about)September 20267 min read The sequence in all six cases · prolonged GI symptoms · rapid, substantial weight loss · altered mental status, · eye movement abnormalities · The first two are the warning. The last two are the emergency. **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms). ## Key takeaways - A systematic review identified six published cases of Wernicke's encephalopathy, a thiamine deficiency disorder, following semaglutide treatment for obesity. - All six had prolonged gastrointestinal symptoms and substantial weight loss before any neurological signs appeared. - Presentations included altered mental status and abnormal eye movements. Outcomes were poor in several cases, including progression to Korsakoff syndrome and death. - Six case reports cannot produce a rate. They establish that it happens, not how often. It can, and six published cases prove it happens. A systematic review searched four databases for Wernicke’s encephalopathy after semaglutide prescribed for obesity. It found six [\[1\]](https://thisglp.com/research/can-a-glp1-cause-thiamine-deficiency#ref-1). Wernicke’s is what severe thiamine deficiency does to the brain. Thiamine is stored for a matter of weeks. That is short next to how long someone can spend eating very little and vomiting. The broader nutrient picture is in [vitamins and minerals on a GLP-1](https://thisglp.com/research/do-you-need-vitamins-on-a-glp1). A narrative review sets the wider context [\[2\]](https://thisglp.com/research/can-a-glp1-cause-thiamine-deficiency#ref-2). Thiamine is one of several micronutrients this drug class is associated with depleting. The route is reduced intake, not impaired absorption. A separate meta-analysis measured what happens to nutritional intake during treatment [\[3\]](https://thisglp.com/research/can-a-glp1-cause-thiamine-deficiency#ref-3). Intake is the mechanism. The drug does not consume thiamine. The person stops eating enough of it. Six cases is not a frequency Millions of people take these drugs. Six published reports establish that this can happen and say nothing whatever about how often it does. Case reports have no denominator, and reaching publication requires a clinician to have recognized the syndrome, written it up, and had it accepted — a filter that removes most of what occurs. Nobody should read this as a common event, and nobody should read it as a reason to stop treatment. The reason it is worth a reader’s attention anyway is the shape of the sequence, which was the same in every case. Prolonged gastrointestinal symptoms came first. Substantial and rapid weight loss followed. Only then did neurological deterioration appear, presenting as altered mental status and abnormalities of eye movement. The first two stages are visible to the person experiencing them, which makes this a rare harm with an early warning attached. The outcomes are the reason not to soften any of this. Several cases did badly. One progressed to Korsakoff syndrome, an irreversible amnesic disorder. One ended in death. Wernicke’s is treatable. Treated early with parenteral thiamine, the damage is largely preventable. Left late, it is not. The practical translation is narrow. Persistent vomiting for weeks is not a side effect to push through. Neither is an inability to keep food down. Rapid weight loss on top of either compounds the problem rather than signaling success. That combination is a reason to contact a prescriber. The dose-escalation period is when it is most likely to arise, as [titration and nausea](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1) describes. Nothing here is an argument for taking a supplement on your own initiative. Deficiency severe enough to reach the brain is a clinical emergency. It is treated with injections under supervision. A tablet from a shelf does not address it once symptoms have started. The general problem underneath is eating much less while needing the same nutrients. It sits beside the muscle question in [what these drugs do to muscle](https://thisglp.com/research/muscle-loss-on-glp1). The broader tolerability picture is in [the network meta-analysis of nineteen drugs](https://thisglp.com/research/the-best-losers-are-the-worst-tolerated). ## Frequently asked How common is this? Unknown, and this review cannot establish it. Six published case reports have no denominator, so they show the event is possible without indicating any rate. What are the warning signs? In every case, prolonged gastrointestinal symptoms and substantial rapid weight loss came first, followed by confusion or altered mental state and abnormal eye movements. The later signs are a medical emergency. Should I take a thiamine supplement? That is a question for a prescriber, not something to start independently. Deficiency severe enough to affect the brain is treated with injections under medical supervision, and the useful action is reporting persistent vomiting rather than self-supplementing. ## Sources 1. \[1\] Bidesie J, Oudman E (2026). Wernicke's Encephalopathy Following Semaglutide Treatment for Obesity: A Systematic PRISMA Review of Case-Based Evidence Obesity (Silver Spring, Md.). [PMID 42399213](https://pubmed.ncbi.nlm.nih.gov/42399213/) 2. \[2\] Urbina J, et al. (2026). Micronutrient and Nutritional Deficiencies Associated With GLP-1 Receptor Agonist Therapy: A Narrative Review Clinical Obesity. [PMID 41549912](https://pubmed.ncbi.nlm.nih.gov/41549912/) 3. \[3\] Quan AT, Nguyen HL, Nguyen TMT (2026). Nutritional intake changes during GLP-1 receptor agonist therapy: A systematic review and meta-analysis Diabetes & Metabolic Syndrome. [PMID 42508090](https://pubmed.ncbi.nlm.nih.gov/42508090/) ## More in Safety - [ Medication list · Check combinations · Fluid loss · Changes kidney risk · Pharmacist · Choose a safe option ### Can You Take Ibuprofen With Ozempic? Check Kidney and Stomach Risks ](https://thisglp.com/research/can-you-take-ibuprofen-with-ozempic) - [ 1.9% · Placebo · 8.5% · Ozempic 0.5 mg · 8.8% · Ozempic 1 mg ### Does Ozempic Cause Diarrhea? Rates, Timing, and When to Call ](https://thisglp.com/research/does-ozempic-cause-diarrhea) - [ Sit down · Prevent a fall · Check context · Glucose and fluids · Get help · Severe symptoms ### Does Ozempic Cause Dizziness? What to Check First ](https://thisglp.com/research/does-ozempic-cause-dizziness)